Standard Template Labs | $49,000,000 | (Mar 18, 2026)
Surf AI(1) | $57,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
OrthoLazer
United States
- Rochester, New York
- 23/10/2024
- Series A
- $7,000,000
OrthoLazer Orthopedic Laser Centers offer both patients and their orthopedic doctors an innovative and effective alternative pain management option to treat acute and chronic orthopedic conditions. Founded by Dr. Scott Sigman – the original opioid-sparing surgeon – these centers further his mission of providing his patients non-operative and non-opioid treatment options. The overwhelming patient response to his first OrthoLazer Center led to the new initiative to make OrthoLazer Centers available to patients nationwide.
OrthoLazer Orthopedic Laser Centers are powered by the exclusive MLS M8 Robotic Laser. This FDA-cleared and patented technology treats the pain and inflammation associated with a wide variety of soft tissue injuries, nerve pain, arthritis and surgery with no known side effects. Additionally, the MLS M8 Robotic Laser is the only high-powered laser that is non-invasive, painless, and completely free of the side effects and risks associated with other lasers used in the market today.
- Industry Medical Practices
- Website https://ortholazer.com/
- LinkedIn https://www.linkedin.com/company/ortholazer/
Related People
Rod MayerFounder
United States -
Warsaw, Indiana
Servant leader passionate about changing the way business is done while doing so one relationship at a time.
Quorus | $5,000,000 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
Malama Health | $9,200,000 | (Mar 17, 2026)
Understood Care | $5,000,000 | (Mar 17, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)
Gangkhar | $4,250,000 | (Mar 17, 2026)
Certiv | $4,200,000 | (Mar 17, 2026)
Zero RFI | $13,800,000 | (Mar 17, 2026)